CF Industries (CF) Q3 2025 earnings summary

Executive summary

• Net earnings attributable to common stockholders were $1.05 billion for the first nine months and $353 million for Q3 2025, with adjusted EBITDA of $2.07 billion, reflecting strong operational performance and favorable nitrogen market conditions.

• Diluted EPS for Q3 2025 was $2.19, up 41% year-over-year, aided by higher net earnings and a 10% reduction in weighted-average shares outstanding from share repurchases.

• Achieved a 25% reduction in GHG emissions intensity since 2020, completed major emissions abatement projects, and began sales of certified low-carbon ammonia at premium prices.

• Completed a $3 billion share repurchase program and launched a new $2 billion authorization in October 2025, reducing outstanding shares by 19% since 2022.

• Initiated the Blue Point low-carbon ammonia joint venture with JERA and Mitsui, and advanced CCS projects at Yazoo City.

Financial highlights

• Nine-month 2025 net sales were $5.21 billion, up from $4.41 billion year-over-year; Q3 net sales were $1.66 billion, up from $1.37 billion.

• Gross margin for the first nine months was $1.96 billion (37.6% of sales), with Q3 gross margin at $632 million (38.1%).

• Free cash flow for the trailing twelve months was $1.7 billion, with a 65% conversion rate from adjusted EBITDA.

• Cash and cash equivalents as of September 30, 2025, were $1.84 billion.

• Returned $1.3 billion to shareholders in the first nine months of 2025.

Outlook and guidance

• Gross ammonia production for 2025 projected at approximately 10 million tons.

• Capital expenditures for 2025 projected at $925 million, including $575 million for existing operations and $300–$400 million for Blue Point.

• Construction of the Blue Point facility to begin in 2026, with production starting in 2029; total project cost estimated at $3.7 billion.

• CCS and abatement projects expected to add $150–$200 million in annual free cash flow by decade's end.

• Management expects continued strong global nitrogen demand and tight market conditions through 2026.